Related Experiment Video
Updated: Jul 24, 2026

08:48
Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
Published on: January 26, 2016
Phenyl beta-methoxyacrylates: a new antimalarial pharmacophore.
J Alzeer1, J Chollet, I Heinze-Krauss
1Pharma Research, Preclinical Infectious Diseases, F. Hoffmann-La Roche Ltd., CH-4070 Basel, Switzerland.
Journal of Medicinal Chemistry
|February 26, 2000
Summary
Novel phenyl beta-methoxyacrylates show promise as inexpensive antimalarial drugs. These compounds inhibit mitochondrial electron transport and demonstrate superior potency to chloroquine in preclinical studies.
Area of Science:
- Medicinal Chemistry
- Parasitology
- Biochemistry
Background:
- Antimalarial drug resistance necessitates the development of new therapeutic agents.
- Phenyl beta-methoxyacrylates are a novel class of compounds with potential antimalarial activity.
- The mechanism of action is hypothesized to involve inhibition of mitochondrial electron transport.
Purpose of the Study:
- To synthesize and evaluate phenyl beta-methoxyacrylates as antimalarial agents.
- To establish structure-activity relationships for antimalarial potency.
- To compare the efficacy of novel compounds against chloroquine.
Main Methods:
- Chemical synthesis of a series of phenyl beta-methoxyacrylate analogs.
- In vitro antimalarial activity testing against Plasmodium falciparum.
- In vivo efficacy studies in a murine malaria model.
- Structure-activity relationship analysis.
Main Results:
- Optimal antimalarial activity was observed when the beta-methoxyacrylate group was ortho to the linker.
- The (E,E)-butadiene bridge provided the highest potency.
- Ortho-substitution or ortho,para-disubstitution on the second aromatic ring enhanced efficacy.
- Several synthesized compounds exhibited superior antimalarial activity compared to chloroquine in both culture and murine models.
Conclusions:
- Phenyl beta-methoxyacrylates represent a promising new class of antimalarial drug candidates.
- Specific structural modifications, including linker and substitution patterns, are critical for optimizing potency.
- These compounds offer a potential alternative to existing antimalarials, particularly in the face of resistance.
Related Concept Videos
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...

